| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.37B | +78.3% |
| R&D Expense | $1.8M | +50.0% |
| SG&A Expense | $219.5M | +21.9% |
| Operating Income | -$49.2M | +14.6% |
| Interest Expense | $28.0M | -30.3% |
| Pre-tax Income | -$77.1M | +32.2% |
| Income Tax | -$3.1M | -29.2% |
| Net Income | -$48.2M | -162.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.23B | +32.7% |
| Accounts Receivable | $205.9M | +122.1% |
| Inventory | $3.5M | +133.3% |
| Current Assets | $1.45B | +40.6% |
| Total Assets | $2.34B | +31.7% |
| Current Liabilities | $183.8M | +84.9% |
| Long-term Debt | $1.74B | +69.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.0M | -87.2% |
| Capital Expenditures | $8.2M | +70.8% |
| Investing Cash Flow | -$170.5M | -67.0% |
| Financing Cash Flow | $471.2M | -53.0% |
| Free Cash Flow | -$5.2M | -128.0% |
| Total Liabilities |
| $1.94B |
| +75.1% |
| Stockholders' Equity | $272.8M | -40.6% |